May 19, 2021 – Amazon is considering launching a business that offers an array of at-home medical tests and a third-party marketplace for general home-diagnostics services, according to Insider.
The company is in talks to first launch its own COVID-19 testing kit in June, potentially around the start of its annual Prime Day shopping event, according to people directly involved in the matter.
In March, the Food and Drug Administration (FDA) gave clearance for Amazon’s at-home COVID-19-testing product, which was developed by Amazon subsidiary STS Lab Holdco.
Insider also reported that Amazon could expand its business to offer testing kits for infections that lead to respiratory and sexually transmitted infections. Amazon’s long-term goal is to expand into other areas, such as clinical genomics, and launch a third-party marketplace that sells medical tests from other companies, people familiar with the matter told the publication.
The initiative is led by the team that built Amazon’s in-house COVID-19 testing lab, internally code-named Project Ultraviolet. The team is already being referred to as “Amazon Diagnostics” internally and could start using the Diagnostics brand publicly when the testing kits launch.
There are several long-term plans for Amazon Diagnostics, including a third-party marketplace for home tests and genomic testing, the sources said. The marketplace would have third-party labs offering diagnostic tests directly to consumers through a website called Amazon Dx.
Learn More
(Paid Subscription Required)